Showing 1 - 2 results of 2 for search 'Ruemu E. Birhiray', query time: 0.03s Refine Results
  1. 1
    PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6

    PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF... by Saulius K. Girnius, Joshua Richter, Roger M. Lyons, Kimberly Bogard, Sudhir Manda, Ruemu E. Birhiray, Habte A. Yimer, Kim Tran, Suman Kambhampati, Jyoti Arora, Stephen Noga, Robert Rifkin

    Published 2023-08-01
    Get full text
    Article
  2. 2
    In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management

    In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management by Robert M. Rifkin, Saulius K. Girnius, Stephen J. Noga, Ruemu E. Birhiray, Suman Kambhampati, Sudhir Manda, Roger M. Lyons, Habte A. Yimer, Dasha Cherepanov, Eric Lloyd, Presley Whidden, Joshua Richter

    Published 2023-09-01
    Get full text
    Article

Search Tools: